A DNA Origami-Based Gene Editing System for Efficient Gene Therapy in Vivo

Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202315093. doi: 10.1002/anie.202315093. Epub 2023 Nov 14.

Abstract

DNA nanostructures have played an important role in the development of novel drug delivery systems. Herein, we report a DNA origami-based CRISPR/Cas9 gene editing system for efficient gene therapy in vivo. In our design, a PAM-rich region precisely organized on the surface of DNA origami can easily recruit and load sgRNA/Cas9 complex by PAM-guided assembly and pre-designed DNA/RNA hybridization. After loading the sgRNA/Cas9 complex, the DNA origami can be further rolled up by the locking strands with a disulfide bond. With the incorporation of DNA aptamer and influenza hemagglutinin (HA) peptide, the cargo-loaded DNA origami can realize the targeted delivery and effective endosomal escape. After reduction by GSH, the opened DNA origami can release the sgRNA/Cas9 complex by RNase H cleavage to achieve a pronounced gene editing of a tumor-associated gene for gene therapy in vivo. This rationally developed DNA origami-based gene editing system presents a new avenue for the development of gene therapy.

Keywords: DNA Origami; Drug Delivery; Gene Editing; Gene Therapy; Self-Assembly.

MeSH terms

  • CRISPR-Cas Systems* / genetics
  • DNA / genetics
  • Gene Editing*
  • Genetic Therapy
  • RNA, Guide, CRISPR-Cas Systems

Substances

  • RNA, Guide, CRISPR-Cas Systems
  • DNA